|
1. Novo Nordisk inks $2.1B oral obesity drug deal Full story
2. FDA partially pauses cancer drug trial after patient death Full story
3. Corewell Health scaled automation across 21 hospitals. Learn how here.
4. GLP-1s tied to higher osteoporosis risk, studies suggest Full story
5. FDA lifts hold on Intellia trial Full story
6. Inside one AMC's approach to proactive staffing across 53 ORs here.
7. FDA unveils pathway for ultra-rare disease therapies Full story
8. 12 drugs in shortage Full story
Becker's Learning Opportunities
9. Virtual behavioral health carries real risk — 20 criteria hospital leaders should evaluate now, here.
10. Inside a closed-door session on payer-provider collaboration. What CEOs & CFOs actually think here.
11. Normalizing cost conversations is no longer optional. Learn why (and what to do about it) here.
12. Interested in more? See Becker’s full lineup of
webinars
and
whitepapers.
Apply to attend complimentary as a guest reviewer here! Opportunity exclusive to those directly employed by a provider organization.
|
.png)
